Louphrasitthiphol Pakavarin ＬｏｕｐｈｒａｓｉｔｔｈｉｐｈｏｌＰａｋａｖａｒｉｎ

Researcher Number	60897081
Other IDs	https://orcid.org/0000-0001-6546-332X
Affiliation (Current)	2025: 筑波大学, 医学医療系, 客員研究員
Affiliation (based on the past Project Information) *help	2024: 筑波大学, 医学医療系, 客員研究員 2021 – 2022: 筑波大学, 医学医療系, 助教
Review Section/Research Field	Principal Investigator Basic Section 50010:Tumor biology-related
Keywords	Principal Investigator Transcriptomics / Acquired drug resistance / AHR / Cancer stem cells / MITF/TFEB/TFE3 / Plasticity / Phenotypic heterogeneity / Dormancy / Transcription quescence / OSCAR … More / ISR / PDAC / TFE3 / TFEB Less

Research Projects
(2 results)
Research Products
(1 results)

Investigate the feasibility of altering cancer drug sensitivity through modulation of AHR activityPrincipal Investigator
- Principal Investigator
  
  Louphrasitthiphol Pakavarin
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  University of Tsukuba
Targeting MiT transcription factors as a novel therapeutic approach to disru pt the adaptive response to microenvironmental stresses that gives rise to d ormant and cancer stem cellPrincipal Investigator
- Principal Investigator
  
  Louphrasitthiphol Pakavarin
- Project Period (FY)
  2021 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  University of Tsukuba

All Presentation

[Presentation] Metabolic/therapeutic stresses induce generation of persister cells through deregulated TFE3 and ISR.2022
- Author(s)
  Pakavarin Louphrasitthiphol
- Organizer
  Ludwig Cancer Research Annual Retreat
- Invited
- Data Source
  KAKENHI-PROJECT-21K15524